Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Trading Update

10 Dec 2020 07:00

RNS Number : 1416I
Quixant PLC
10 December 2020
 

10 December 2020

Quixant plc

("Quixant" or "the Group")

 

Second Half Profitable Trading Exceeds Expectations

 

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, provides the following update on trading for the current financial year, ending 31 December 2020.

 

The Board is pleased to report that since the release of the Group's interim results on 30 September 2020, trading in its core gaming market has exceeded expectations. As a result, the Group now expects to report full year adjusted profit before tax of at least $1m on revenue of at least $61m.

Jon Jayal, CEO of Quixant, commented:

 

"Given the magnitude of the impact of Covid-19 on the global gaming industry, I am delighted that trading has recovered to the extent that we will be able to more than offset the loss in the first half and report a profit for the year. Our business has been supported by the resiliency of Densitron through the pandemic, enabling us to also maintain a strong net cash position.

 

"While the macro-economic environment remains uncertain, there are encouraging signs our customers are preparing for improving conditions during 2021. With strict financial discipline, a strong balance sheet and close relationships with our customers, I believe we are well-placed to drive long-term, profitable growth."

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer

Andrew Jarvis, Interim Chief Financial Officer

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (ECM)

Financial PR:

Tel: +44 (0)20 3405 0205

Alma PR

John Coles / David Ison / Kieran Breheny

 

About Quixant

 

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKLFBBLLLFBL
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.